Rexahn Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial … – Wall Street Journal
Rexahn Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial …Wall Street JournalThe trial is a multi-center study designed to evaluate the efficacy of Archexin in combination with everolimus (Afinitor(R)) to treat metastatic RCC patien…